Astrocytoma Market Research Report 2032

The Astrocytoma market is anticipated to increase, due to an increase in the incidence of brain tumors and the anticipated launch of novel therapies.

DelveInsight’s Astrocytoma market report thoroughly explains Astrocytoma, historical and forecasted epidemiology, as well as the Astrocytoma market trends in the 7MM. 

Some of the Key Highlights from the Astrocytoma Market Report

  • According to Crocetti et al., astrocytic tumor incidence rates vary significantly among European areas, ranging from 3/100,000 in Eastern Europe to 5/100,000 in the United Kingdom.
  • According to the National Organization for Rare Disorders (NORD), Anaplastic astrocytoma and glioblastoma multiforme are expected to affect 5-8 persons per 100,000 in the general population.
  • Leading players in the Astrocytoma market include Denovo Biopharma, Orbus Therapeutics, Diffusion Pharmaceuticals, and others.
  • Key Astrocytoma therapies in the pipeline include DB102, Eflornithine, Trans Sodium Crocetinate (TSC), and others.
  • The US FDA and EMA designated DB102 (Denovo Biopharma) as an orphan drug for DLBCL and glioblastoma multiforme (GBM), and the US FDA granted it Fast Track Designation.

Have queries? Request for the sample @ Astrocytoma Market Outlook

View Report: https://www.delveinsight.com/report-store/astrocytoma-market

Astrocytoma Overview

Astrocytoma is a tumor that can develop in the brain or the spinal cord. It starts in nerve-supporting cells called astrocytes and is the most frequent type of brain tumor in adults. Astrocytoma is classified as grade 1 (most benign) to grade 4 (most malignant) by the World Health Organization (WHO).

Astrocytoma Epidemiology Segmentation

The Astrocytoma report proffers epidemiological analysis for the study period 2018-30 in the 7MM segmented into: 

  • Astrocytoma Total Incident Cases 
  • Astrocytoma Grade-Specific Cases 
  • Astrocytoma Total Diagnosed Cases 
  • Astrocytoma Gender-Specific Cases 
  • Astrocytoma Line Wise Treated Cases 

Astrocytoma Treatment Landscape

The current Astrocytoma treatment options include:

  • Surgery
  • Steroids
  • Chemotherapy
  • Radiotherapy
  • Bevacizumab (Avastin)
  • Off Label Therapies (Procarbazine hydrochloride)

View Report: https://www.delveinsight.com/report-store/astrocytoma-market

Astrocytoma Market Outlook

The Astrocytoma market will expand during the forecast period, 2021–2030, due to an increase in the incidence of brain tumors and the anticipated launch of novel therapies such as  DB102, Eflornithine, Trans Sodium Crocetinate (TSC), and others.

Discover more about the future market share of the drugs @ Astrocytoma Market Analysis

Astrocytoma Pipeline Therapies and Key Companies 

  •  DB102: Denovo Biopharma
  • Eflornithine: Orbus Therapeutics
  • Trans Sodium Crocetinate (TSC): Diffusion Pharmaceuticals

View Report: https://www.delveinsight.com/report-store/astrocytoma-market

Table of Contents 

1.

Key Insights

2.

Executive Summary of Astrocytoma

3.

SWOT Analysis of Astrocytoma

4.

Astrocytoma: Market Share (%) Distribution Overview at a Glance: By Country

5.

Epidemiology and Market Methodology

6.

Astrocytoma: Disease Background and Overview

7.

Epidemiology and Patient Population

8.

Epidemiology Scenario: 7MM

9.

The United States Epidemiology

10.

EU-5 Epidemiology

11.

Japan Epidemiology

12.

Current Treatment Practices

13.

Unmet Needs

14.

Patient Journey of Astrocytoma

15.

Key Endpoints in Astrocytoma Clinical Trials

16.

Marketed Therapies

17.

Emerging Therapies

18.

Conjoint Analysis of Astrocytoma

19.

Astrocytoma: Eight Major Market Analysis

20.

7MM Market Size

21.

United States Market Size

22.

EU-5 Market Size

23.

Japan Market Size

24.

Market Access and Reimbursement of Astrocytoma Therapies

25.

Market Drivers

26.

Market Barriers

27.

Appendix

28.

DelveInsight Capabilities

29.

Disclaimer

30.

About DelveInsight

 

DelveInsight’s Competitive Intelligence Service includes a multidimensional coverage, helping to keep track of competitors and gain traction in the dynamic market by overcoming the challenges and expediting business growth through a strategic and tactical approach.

Other Reports:

Related Blogs:

About Delveinsight: 

DelveInsight Business Research is a leading Market Research, and Business Consultant focused purely on Healthcare. It helps pharma companies by providing them with end-to-end services to solve their business problems.

Get hold of all the Pharma and healthcare market research reports on our market research subscription-based platform PharmDelve.

Media Contact

Company Name: DelveInsight Business Research LLP

Contact Person: Ankit Nigam

Email: info@delveinsight.com

Phone: +19193216187

City: Albany

State: New York

Country: United States

Website: https://www.delveinsight.com/

Connect With Us at:

LinkedIn | Facebook | Twitter

Comments

Post a Comment

Popular posts from this blog

How Competitive intelligence is transforming the scenario for Biotech firms?

What is Competitive intelligence service? Competitive intelligence ideally means gathering information on rival business in the market, analyse the information and use the information to strategize to yield positive results. Going by the definition, competitive intelligence assembles actionable information from diverse published and unpublished sources, collected efficiently and ethically. So, analysts performing Competitive intelligence for their clienteles present a detailed picture of the marketplace, forthcoming challenges and the ways to face them, even before the can harm the client’s business. What could it mean? Competitive intelligence can often give a wrong idea, as it may misunderstood as a service which can help gain an advantage over the rivals. However, this is not the case. Competitive intelligence is an ethical and legal practise undertaken involving the study of analytical data, analysing the market and optimizing the relevant and realistic strategies t
Read more

Vernal Keratoconjunctivitis Market

(Albany, US) DelveInsight’s “ Vernal Keratoconjunctivitis Market  Insights, Epidemiology, and Market Forecast-2030 ” report provides an in-depth understanding of the disease, historical and forecasted epidemiology, as well as Vernal Keratoconjunctivitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Some of the key facts of the  Vernal Keratoconjunctivitis Market The increasing population and rising prevalence of Vernal Keratoconjunctivitis generates a large patient population in the global market. In 2017, a total of 4,752,356 patients were affected by Vernal Keratoconjunctivitis in the global market. China contributes the largest share among EU-5, and Japan, with 2,248,706 cases in 2017. The total diagnosed prevalent population of Vernal Keratoconjunctivitis was 2,943,057 in the global market.   Request for Sample Report: https://www.delveinsight.com/report-store/vernal-kerato
Read more

Analyzing the Rising Trend of Telehealth In the Arab Countries

Telehealth is one of the most trending aspects of the healthcare segment in today’s time. It is significantly changing the functioning of healthcare. Now the patient can connect with the doctor sitting in any part of the world. With this, long-distance consultations are possible too at any time of the day. Along with medical consultation, Telehealth is used for medical education, communications, and enhancing the necessary knowledge and skills of the healthcare professionals.  Today, the countries in the MENA region are actively adopting Telehealth in their healthcare system. Earlier, the countries have issues such as lack of digital infrastructure, business incentives, regulatory frameworks & policies, cyber security threats, etc.  Over the years, some countries like UAE, Saudi Arabia, Bahrain, and Oman have taken proactive steps to overcome these challenges and enhanced telehealth adoption. Governments are also making substantial investments in both healthcare and Telehealth. Sev
Read more